Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Lapatinib | 0.1 | uM | 7 | 625.00 | 270.29 | 1059.00 | 712.50 | 1.4863 | 1.6553 |
| BT-20 | Lapatinib | 0.031623 | uM | 7 | 625.00 | 270.29 | 959.00 | 712.50 | 1.3460 | 1.4735 |
| BT-20 | Linsitinib | 3.1623 | uM | 7 | 625.00 | 270.29 | 783.00 | 712.50 | 1.0989 | 1.1396 |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 858.00 | 712.50 | 1.2042 | 1.2842 | |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 625.00 | 270.29 | 817.00 | 712.50 | 1.1467 | 1.2056 |
| BT-20 | Linsitinib | 0.31623 | uM | 7 | 625.00 | 270.29 | 756.00 | 712.50 | 1.0611 | 1.0866 |
| BT-20 | Linsitinib | 0.1 | uM | 7 | 625.00 | 270.29 | 659.00 | 712.50 | 0.9249 | 0.8914 |
| BT-20 | Erlotinib | 1 | uM | 7 | 625.00 | 270.29 | 705.00 | 712.50 | 0.9895 | 0.9849 |
| BT-20 | Linsitinib | 19.9526 | uM | 7 | 625.00 | 270.29 | 423.00 | 712.50 | 0.5937 | 0.3775 |
| BT-20 | Erlotinib | 0.031623 | uM | 7 | 625.00 | 270.29 | 766.00 | 712.50 | 1.0751 | 1.1063 |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 662.00 | 712.50 | 0.9291 | 0.8976 | |
| BT-20 | 17-AAG | 3.1623 | uM | 7 | 625.00 | 270.29 | 284.00 | 712.50 | 0.3986 | 0.0360 |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 673.00 | 712.50 | 0.9446 | 0.9201 | |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 2.00 | 712.50 | 0.0028 | -0.9701 | |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 2.00 | 712.50 | 0.0028 | -0.9701 | |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 696.00 | 712.50 | 0.9768 | 0.9668 | |
| BT-20 | 17-AAG | 10 | uM | 7 | 625.00 | 270.29 | 240.00 | 712.50 | 0.3368 | -0.0815 |
| BT-20 | 17-AAG | 0.0016596 | uM | 7 | 625.00 | 270.29 | 780.00 | 712.50 | 1.0947 | 1.1337 |
| BT-20 | Lapatinib | 0.0033113 | uM | 7 | 625.00 | 270.29 | 809.00 | 712.50 | 1.1354 | 1.1902 |
| BT-20 | Erlotinib | 0.01 | uM | 7 | 625.00 | 270.29 | 741.00 | 712.50 | 1.0400 | 1.0569 |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 874.00 | 712.50 | 1.2267 | 1.3146 | |
| BT-20 | Erlotinib | 3.1623 | uM | 7 | 625.00 | 270.29 | 714.00 | 712.50 | 1.0021 | 1.0030 |
| BT-20 | Lapatinib | 0.0016596 | uM | 7 | 625.00 | 270.29 | 690.00 | 712.50 | 0.9684 | 0.9546 |
| BT-20 | Linsitinib | 1 | uM | 7 | 625.00 | 270.29 | 960.00 | 712.50 | 1.3474 | 1.4753 |
| BT-20 | Lapatinib | 3.1623 | uM | 7 | 625.00 | 270.29 | 686.00 | 712.50 | 0.9628 | 0.9465 |